Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04779918 · ClinicalTrials.gov registry record · NA
Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
A NA study of Hernia, Ventral and Hernia, Inguinal, sponsored by Tela Bio.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 10
- Study locations
NCT04779918: Recruiting NA study of Hernia, Ventral and Hernia, Inguinal, sponsored by Tela Bio.
NCT04779918 is a NA study of Hernia, Ventral and Hernia, Inguinal that is actively recruiting participants, run by Tela Bio. The registered enrollment target is 160 participants, roughly in line with the 161-participant average among 7 other Hernia, Ventral trials with a reported enrollment target. The trial reports 10 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04779918, a NA study of Hernia, Ventral and Hernia, Inguinal, is actively recruiting participants, sponsored by Tela Bio.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 10
- Study locations
Study Summary
This study is designed to evaluate the post-operative complications and hernia recurrence following the use of OviTex in subjects with ventral or inguinal hernias. Up to 160 subjects will participate in the study from up to 20 investigator sites.
Primary Outcome
Incidence of early peri- and post-operative surgical site occurrences or wound related events noted at the hernia repair site
Conditions Studied
Interventions
- DEVICE OviTex Reinforced Tissue Matrix
Study Locations (10)
Florida
- GenesisCare - Destin
- Surgical Healing Arts Center - Fort Myers
New York
- St. Francis Hospital - Roslyn
- Mohawk Valley Health System - Utica
Alabama
- University of South Alabama - Mobile
Colorado
- SurgOne - Denver
Kansas
- St. Luke's Hospital - Overland Park
Kentucky
- University of Louisville - Louisville
Michigan
- Munson Healthcare - Traverse City
Texas
- Houston Methodist - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2021-04-29 |
| Est. Completion | 2027-12-30 |
| Phase | NA |
What NCT04779918 shows while recruiting
NCT04779918 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 161-participant average among 7 other Hernia, Ventral trials with a reported enrollment target.
The record links to 2 conditions, with Hernia, Ventral appearing as the primary indexed condition, and to 1 intervention - of which OviTex Reinforced Tissue Matrix is the first listed.
NCT04779918 lists 10 locations in 8 states (Florida, New York, Alabama).
Frequently Asked Questions
What is clinical trial NCT04779918 about?
NCT04779918 is a clinical study titled "Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh". This study is designed to evaluate the post-operative complications and hernia recurrence following the use of OviTex in subjects with ventral or inguinal hernias. Up to 160 subjects will participate in the study from up to 20 investigator sites.
What is the current status of trial NCT04779918?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2021-04-29. Estimated completion is 2027-12-30.
What conditions does trial NCT04779918 study?
This clinical trial studies the following conditions: Hernia, Ventral, Hernia, Inguinal.
What interventions are being tested in trial NCT04779918?
The interventions under investigation include: OviTex Reinforced Tissue Matrix (DEVICE).
Who is sponsoring clinical trial NCT04779918?
This trial is sponsored by Tela Bio, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04779918 being conducted?
This trial has 10 study locations across Alabama, Colorado, Florida, Kansas, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hernia, Ventral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
GORE® ENFORM Biomaterial Product Study
RECRUITING · NA
-
Transorb™ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia
ACTIVE NOT RECRUITING · NA
-
RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction
COMPLETED · NA
-
Laparoscopic Ventral Hernia Repair With Elastomeric Pain Pump
COMPLETED · NA
-
A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot
RECRUITING
-
Abdominal Wall Tension in Patients Undergoing Ventral Hernia Repair Without Component Separation
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI